By a News Reporter-Staff News Editor at Biotech Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Synageva Biopharma Corp. (Form S-8) was posted on June 26, 2014.
The SIC code for this company is 2836, Biological Products, (No Diagnostic Substances).
There were 4 documents filed with this form. The SEC file number is 0001193125-14-251115.
The contact information for this company is 33 HAYDEN AVE., LEXINGTON MA 02421, (781) 357-9900.
Our editors provided additional information about Form S-8: This form is used for the registration of securities to be offered to an issuer’s employees pursuant to certain plans.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/911326/0001193125-14-251115-index.html.
Keywords for this news article include: Pharmaceutical Companies, Drugs, Therapy, SEC Filing, Biopharmaceuticals, Biological Products, Synageva Biopharma Corp., (No Diagnostic Substances).
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC